Revive Therapeutics has announced the appointment of Craig Leon, Revive's chairman of the board, as chief executive officer. Fabio Chianelli, Revive's current chief executive officer, will continue as president. These changes will permit Leon to dedicate his efforts to executing the company's capital markets and business development strategies, while permitting Chianelli to focus on directing the company's corporate operations and research and development programs.
Chianelli said, "Mr. Leon and I share a vision of Revive's potential. As president, I look forward to focusing on the company's research and development and operational excellence."
"I have had the pleasure of working with Mr. Chianelli for many years and I look forward to the challenges and opportunities presented with this engagement," said Leon. "I am proud of the company's successes to date and we will continue to build on increasing awareness within the investment and pharmaceutical communities while we continue to focus on advancing Revive's product pipeline through clinical trials towards regulatory approval."